Differences in Hematopoietic Cell Transplantation Outcomes by HIV status, California, 1991-2016.

Kurt A David¹, Ann Brunson², Sara J Schonfeld³, Alex J Fauer⁴, Shuai Chen⁵, Roland Zepf⁶, Laura Fejerman⁵, Christa Meyer⁷, Jeffery J Auletta⁸, Lori Muffly⁹, Lindsay M Morton³, Sheryl L Catz⁴, Theresa H M Keegan²

¹University of California, Davis, School of Nursing, Sacramento, CA. Electronic address: KurtDavidRNMS@gmail.com.

²Center for Oncology Hematology Outcomes Research and Training (COHORT), Division of Hematology and Oncology, University of California Davis Comprehensive Cancer Center, Sacramento, CA.

³Radiation Epidemiology Branch, Division of Cancer Epidemiology and Genetics, National Cancer Institute, National Institutes of Health, Department of Health and Human Services, Bethesda, MD.

⁴University of California, Davis, School of Nursing, Sacramento, CA.

⁵University of California, Davis, Comprehensive Cancer Center, Sacramento, CA.

⁶University of California, San Francisco, School of Nursing Community Health Systems, San Francisco, CA.

⁷Center for International Blood and Marrow Transplant Research, National Marrow Donor Program, Minneapolis, MN.

⁸Center for International Blood and Marrow Transplant Research, National Marrow Donor Program, Minneapolis, MN; Divisions of Hematology/Oncology/BMT and Infectious Diseases, Nationwide Children's Hospital, Columbus, OH.

⁹Division of Blood and Marrow Transplantation and Cellular Therapy, Stanford University, Stanford, CA.

PubMed DOI

Abstract

BACKGROUND: Hematopoietic cell transplantation (HCT) can be curative for lymphoma, yet population-level HCT outcomes by HIV status are not well studied, contributing to variable access to HCT for people with HIV. OBJECTIVE(S): The purpose of this study is to evaluate if there are differences in clinical outcomes, hospital utilization, and overall survival following HCT between the cohorts. STUDY…

Create a free account to keep reading

Free members get 10 full research views every month across publications, clinical trials, FDA clearances, adverse events, and NIH grants. No credit card required.

Create Free Account Sign In

Want unlimited research access? See Pro plans

Data Accuracy Notice: Research intelligence on Health AI Central is aggregated from public sources (PubMed, ClinicalTrials.gov, FDA, NIH, CMS, and others) and refreshed nightly. Classifications and derived metrics are produced by automated methods described in our Methodology. We recommend verifying critical data points against the primary sources before making decisions.